PCV

(redirected from polycythemia vera)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to polycythemia vera: Polycythemia rubra vera
Category filter:
AcronymDefinition
PCVPositive Crankcase Ventilation
PCVPollution Control Valve
PCVPacked Cell Volume
PCVPneumococcal Conjugate Vaccine
PCVPorcine Circovirus (virus)
PCVPurge Control Valve
PCVPartido Comunista de Venezuela
PCVParti Communiste Vietnamien (French: Vietnamese Communist Party)
PCVPeace Corps Volunteer
PCVPlacerville (Amtrak station code; Placerville, CA)
PCVPositive Crankcase Ventilation Valve
PCVPassenger Carrying Vehicle
PCVParietal Cell Vagotomy
PCVPressure Control Valve
PCVPath Coding Violation (error condition)
PCVP-Bit Coding Violation (Adtran)
PCVPressure Controlled Ventilation
PCVPolycythemia Vera (blood disorder)
PCVPoly Canyon Village (student housing; California Polytechnic State University)
PCVPercevoir (French: Reverse Charge Call)
PCVPolypoidal Choroidal Vasculopathy
PCVPerceived Customer Value
PCVPrescribed Concentration or Value (UK drinking water quality)
PCVPersonal Color Viewer (software)
PCVPanasonic Communications Vietnam Co., Ltd.
PCVPerformance, Certification, Verification (test)
PCVPowered Combat Vest (gaming)
PCVPiercing the Corporate Veil
PCVPermanent Capital Vehicle (investing)
PCVProduct Category Volume (retail economics)
PCVPlanned Closing Version
PCVPoker Club Valognais (French poker club; Valognes, France)
PCVPrime de Cherté de Vie (French: Premium Cost of Living)
PCVProduct Control Valve
PCVProtection Class Validation (insurance)
PCVPoster Completion Voucher
PCVPayable Chez Vous (French)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
This European approval makes Besremi the first and only approved treatment for polycythemia vera (PV) independent of previous hydroxyurea exposure based on Phase III clinical data.
Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?
His past medical history was significant for heart failure with reduced ejection fraction, polycythemia vera, obstructive sleep apnea, hypertension, hyperlipidemia, aortic stenosis, anemia, chronic kidney disease stage IV, and stroke.
Alvarez-Larran, "How to Treat Essential Thrombocythemia and Polycythemia Vera," Clinical Lymphoma, Myeloma & Leukemia, vol.
Perry, "Coincidental polycythemia vera and multiple myeloma: Case report and review," American Journal of Hematology, vol.
Hasselbalch, "Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?" Blood, vol.
Polycythemia vera is a bone marrow disease marked by the excessive production ofred blood cells and is occasionally accompanied by an increased number of white blood cells and platelets.
The JAK2 p.V617F (c.1849G>T) somatic point mutation is present in almost all patients with polycythemia vera and in a large proportion (40%-50%) of patients with essential thrombocythemia or primary myelofibrosis.
Although those diseases, beta-thalassemia and polycythemia vera, have opposite effects on red blood cell production, treating animals with minihepcidin helps to restore normal levels of red blood cells and reduces spleen enlargement.
Among the 11 previously published cases there were three cases of myelodysplastic syndrome, two cases of acute myeloid leukemia, and one of each of atypical chronic myeloid leukemia, polycythemia vera, polycythemia vera/acute myeloid leukemia overlap, myeloproliferative neoplasia, not otherwise specified, myelodysplastic/myeloproliferative neoplasia overlap, and CEL-NOS.
Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
As model genes, the researchers used JAK2, a gene that when mutated causes a bone marrow disorder known as polycythemia vera; SERPINA1, a gene that when mutated causes alpha 1 anti-trypsin deficiency, an inherited disorder that may cause lung and liver disease; and AAVS1, a gene that's been recently discovered to be a "safe harbor" in the human genome for inserting foreign genes.